Reval
Diepenbeek, 3590, Belgium
NCT Number: NCT01845896
The purpose of this study is to investigate the effects of a combined training programme and a high intensity interval training programme on insulin resistance, muscle strength/ muscle contractile properties, aerobic capacity and body composition in MS patients.
It is assumed that the the above mentioned clinical parameters will improve due to physical exercise.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Diepenbeek, 3590, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: 12 weeks of high intensity interval training or combined exercise
Time frame: change from baseline to 12 weeks
glucose and insulin concentration measurements in blood
Time frame: from baseline to 12 weeks
measurements of cross sectional area and fiber distribution in muscle fibers of the m. vastus lateralis + measurements of enzymatic reactions, ATP, glycogen, ...
Time frame: change from baseline to 12 weeks
by means of an isokinetic dynamometer the muscle strength and endurance will be measured
Time frame: change from baseline to 12 weeks
by means of a submaximal endurance test (ergometer)
Time frame: change from baseline to 12 weeks
measurements of blood cytokine levels
Time frame: Change from baseline to 12 weeks
The self-reported measures contains some questionnaires
Time frame: Change from baseline to 12 weeks
Weight, body fat% and lean tissue% will be assessed by means of a DEXA scan
Bert Op't Eijnde
Other
Rehabilitation in MS: Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02466165
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Diepenbeek, Belgium
View Trial DetailsNCT01718392
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Diepenbeek, Belgium
View Trial DetailsNCT06017726
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
View Trial DetailsNCT03963375
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
St Louis, Missouri, United States
View Trial Details